Procore Insider Kevin O’Connor Trims Holdings Under 10b5-1 Plan
Rhea-AI Filing Summary
Procore Technologies, Inc. (PCOR) – Form 4 insider transaction
Director Kevin J. O’Connor, acting through the Kevin J. O’Connor Revocable Trust, reported the sale of 16,632 shares of Procore common stock on 9-10 July 2025. The dispositions were executed under a pre-arranged Rule 10b5-1 plan dated 21 Nov 2024.
The shares were sold in five blocks at weighted-average prices ranging from $71.27 to $75.06, producing roughly $1.2 million in gross proceeds. After the transactions, the trust’s indirect ownership declined from 1,170,729 shares to 1,154,097 shares, a reduction of about 1.4 %—the filer remains a significant shareholder.
No derivative securities were involved and the filing contains no references to company-specific events, earnings data or new compensation awards. Sales executed pursuant to a 10b5-1 plan generally reduce concerns of opportunistic timing, yet investors often monitor insider selling for potential sentiment signals.
Positive
- Sales executed under a disclosed Rule 10b5-1 plan, reducing concerns over opportunistic trading.
- Insider maintains a sizeable 1.15 million-share position, indicating ongoing confidence in PCOR.
Negative
- Director sold 16,632 shares (~$1.2 million), which some investors may interpret as a bearish signal.
- No offsetting insider purchases were reported, leaving the net insider activity negative.
Insights
TL;DR: Routine 10b5-1 sale; minimal ownership impact, neutral signal.
The 16,632-share disposition equates to roughly 1.4 % of Mr. O’Connor’s holdings and <0.1 % of PCOR’s float. Because the trades were executed under a disclosed Rule 10b5-1 plan, they appear pre-scheduled rather than reactive to near-term news. The insider retains more than 1.15 million shares, suggesting continued alignment with shareholders. From a valuation or earnings-expectations standpoint, the filing is unlikely to be materially impactful.
TL;DR: Insider selling still creates mild overhang despite 10b5-1 protection.
Even planned sales can be interpreted as a modest negative because they increase public float and may hint at portfolio diversification. The transaction’s dollar value (~$1.2 million) is not immaterial, and the market could view any uptick in insider selling activity as a sentiment headwind. Nevertheless, the small percentage of ownership sold tempers the risk. Overall impact leans slightly negative but not thesis-changing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 3,412 | $71.82 | $245K |
| Sale | Common Stock | 4,280 | $72.58 | $311K |
| Sale | Common Stock | 343 | $75.03 | $26K |
| Sale | Common Stock | 5,247 | $72.58 | $381K |
| Sale | Common Stock | 2,445 | $73.41 | $179K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- These shares sold pursuant to a 10b5-1 plan dated November 21, 2024. The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $72.07 to $73.005, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These shares are held by the Kevin J. O'Connor Revocable Trust U/A DTD 06-13-19. The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $73.155 to $73.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $71.27 to $72.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $72.30 to $73.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $75.00 to $75.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
